Home About Journal AHEAD OF PRINT Current Issue Back Issues Instructions Submission Search Subscribe Blog    

Users Online: 934 
Print this page  Email this page Small font sizeDefault font sizeIncrease font size 

 Table of Contents    
Year : 2011  |  Volume : 45  |  Issue : 1  |  Page : 57-62
Osseointegration by bone morphogenetic protein-2 and transforming growth factor beta2 coated titanium implants in femora of New Zealand white rabbits

1 Department of Orthopaedic Surgery, Hannover Medical School, Hannover, Germany
2 Institute for Technical Chemistry, Braunschweig University of Technology, Braunschweig, Germany
3 Helmholtz Centre for Infection Research, Department of Gene Regulation and Differentiation, Braunschweig, Germany
4 Helmholtz Centre for Infection Research, Department of Gene Regulation and Differentiation, Braunschweig;Department of Trauma Surgery, Hannover Medical School, Hannover, Germany

Click here for correspondence address and email

Date of Web Publication7-Dec-2010


Background: Intramembranous bone formation is essential in uncemented joint replacement to provide a mechanical anchorage of the implant. Since the discovery of bone morphogenic proteins (BMPs) by Urist in 1965, many studies have been conducted to show the influence of growth factors on implant ingrowth. In this study, the influence of bone morphogenetic protein-2 (rhBMP-2) and transforming growth factor β2 (TGF-β2) on implant osseointegration was investigated.
Materials and Methods: Thirty-two titanium cylinders were implanted into the femoral condyles of both hind legs of New Zealand White Rabbits. Four experimental groups were investigated: controls without coating, a macromolecular copolymer + covalently bound BMP-2, adsorbed BMP-2, and absorbed BMP-2+TGF-β2. All samples were analyzed by ex vivo high-resolution micro-computed-tomography after 28 days of healing. Bone volume per total volume (BV/TV) was recorded around each implant. Afterward, all samples were biomechanically tested in a pull-out setup.
Results: The highest BV/TV ratio was seen in the BMP-2 group, followed by the BMP-2+TGF-β2 group in high-resolution micro-computed-tomography. These groups were significantly different compared to the control group (P < 0.05). Copolymer+BMP-2 showed no significant difference in comparison to controls. In the pull-out setup, all groups showed higher fixation strength compared to the control group; these differences were not significant.
Conclusions: No differences between BMP-2 alone and a combination of BMP-2+TGF-β2 could be seen in the present study. However, the results of this study confirm the results of other studies that a coating with growth factors is able to enhance bone implant ingrowth. This may be of importance in defect situations during revision surgery to support the implant ingrowth and implant anchorage.

Keywords: BMP-2, TGF-β2, osseointegration

How to cite this article:
Thorey F, Menzel H, Lorenz C, Gross G, Hoffmann A, Windhagen H. Osseointegration by bone morphogenetic protein-2 and transforming growth factor beta2 coated titanium implants in femora of New Zealand white rabbits. Indian J Orthop 2011;45:57-62

How to cite this URL:
Thorey F, Menzel H, Lorenz C, Gross G, Hoffmann A, Windhagen H. Osseointegration by bone morphogenetic protein-2 and transforming growth factor beta2 coated titanium implants in femora of New Zealand white rabbits. Indian J Orthop [serial online] 2011 [cited 2020 Jan 29];45:57-62. Available from:

   Introduction Top

Intramembranous bone formation is essential in uncemented joint replacement to provide a mechanical anchorage of the implant. [1] Analyses in revision surgery have shown wide variations of implant osseointegration. [1],[2] Therefore, other supportive methods to increase bone ingrowth were investigated. Especially in maxillofacial surgery, many studies have been conducted to improve the quality and quantity of implant osseointegration; e.g., improvement of implant biocompatibility and modification of surface characteristics, [3] grafting of autograft-bone or allograft-bone, [4],[5] and modified surgical techniques. [6],[7],[8] Since the discovery of Bone Morphogenetic Proteins (BMPs) by Urist (1965) and their molecular cloning and characterization, they have already found their way into clinical practice for specific indications. [9],[10],[11],[12],[13],[14] BMP-2 and transforming growth factor β (TGF-β) have been shown to stimulate bone ingrowth, gap healing, and implant fixation in several animal studies. [15],[16],[17],[18],[19],[20],[21],[22],[23],[24],[25],[26] Other animal studies have demonstrated that titanium implants are a sufficient carrier for these growth factors. [27],[28],[29],[30],[31],[32]

Thus, the aim of this study was to investigate the influence of bone morphogenetic protein-2 (rhBMP-2) and TGF-b2 on implant osseointegration using high-resolution micro-computed-tomography and biomechanical methods in an animal model of New Zealand White Rabbits.

   Materials and Methods Top

Eight mature New Zealand White Rabbits were used. They were housed in standard laboratory conditions. All animals were fed with autoclaved water and food. All animals were investigated preoperatively by a veterinarian. This included a general health check and an examination of parasites. The study was approved by the Institutional Animal Care and Use Committee, Germany.

Thirty-two implants were designed as titanium cylinders (Ti90Al6V4, ⊗ 3 mm Χ 3 mm, average roughness 95 nm, Goodfellow GmbH, Germany) with an innerthread for the biomechanical test. The innerthread was designed to screw a special manufactured stem in for the pull-out test [Figure 1]. They were divided into four groups according to four different surface chemistries to be tested. Eight control cylinders (group 1) consisted of nonmodified titanium. Eight titanium cylinders were coated with a copolymer as an anchor for rhBMP-2 (group 2): as a copolymer, poly-vinylbenzylphosphonate-co-glycidylmethacrylate (p-VBP-co-GMA) was used to provide a special anchor on the surface of the implant. The coating was done by a dip-coating technique. Afterward, the BMP-2 was bound covalently via the epoxy groups of the polymer and the unbound BMP-2 was removed by a special washing process. The amount of BMP-2 on the surface of each cylinder coated with copolymer was estimated to be > 100 ng/cm 2 by ELISA depending on the layer thickness of the polymer (group 3). Group 3 was made up of eight cylinders which were exposed to 50 μl of BMP2-solution (250 μg/ml), which was allowed to evaporate overnight under sterile conditions. This serves as a positive control of nonspecifically absorbed BMP2. In group 4, the use of a solution of BMP2 plus TGF-b2 (12.5 ng/μl) for nonspecific coating of the cylinders resulted in 12.5 μg BMP2 plus 625 ng TGF-b2 per cylinder. All four different groups of cylinders were implanted in each animal.
Figure 1 :Embedded sample in the MTS Mini Bionix 858 Test Star (MTS Systems Corporation, Minneapolis, USA) for the pull-out test

Click here to view

Operative procedure

The animals were preanesthetized with 25 mg/kg ketamin and 5 mg midazolam intramuscularly. A sterile catheter was placed and the anesthesia was started using propofol. After intubation the anesthesia was maintained with isofluran and a ringer-solution. A broad-spectrum antibiotic (tardomyocel comp. III) and analgesic (buphrenorphin) was applied.

Surgery was done by one surgeon under the same condition. The animals were placed in supine position on the operating table. After disinfection of both hind legs and sterile coverage of the animal, a small skin incision was made with a scalpel above the patella tendon. The incision was moved easily medially or laterally to perform the subcutaneous incision directly to the bone. This technique was used to minimize infection. The second step was to display the medial condyle of the femur. Using a wound spreader, the periosteum and bone could be easily shown. A hand drill (3 mm diameter) was used to drill a hole to fit the implant [Figure 2]. The implant was placed in the cancellous bone using a special inserter. Afterward, the skin was moved for the implantation on the lateral condyle. The same procedure was performed on the other leg. To minimize a systemic failure of different conditions of the cancellous bone in the medial and lateral condyle, the positioning of all cylinders alternated between each animal. The skin was closed with absorbable sutures (Vicryl, Ethicon/Johnson and Johnson, Germany) for healing by primary intention. Three days postsurgery, all animals received 4 mg/kg Carprofen subcutaneously.

After 28 days of surgery, all animals were euthanized to analyze the early implant osseointegration. [33] They were sedated with 10 mg/kg ketamin and euthanized with an overdose pentobarbital (Eutha 77). Both hind legs were extracted, the femoral condyle removed and stored in formalin.
Figure 2 :Intraoperative photograph of an implant in the medial condyle of a New Zealand White Rabbit

Click here to view

High-resolution micro-computed-tomography

All samples were analyzed in an ex vivo high-resolution micro-computed-tomography apparatus (Centre for Synchrotron Radiation, University of Technology, Dortmund, Germany) using synchrotron radiation [Figure 3]. With special adapted software, the region of interest around each titanium cylinder (300 μm) was analyzed. This nondestructive method enables a fast, three-dimensional, and quantitative measurement of the bone tissue around implants. [34] The measurement units were 1 Voxel (35 μm). After a defined segmentation process, a global threshold was defined as barrier between implant and bone and also between bone and soft-tissue. The analysis produces a quotient of bone volume to total volume (BV/TV). These data can be seen as bone ingrowth of implants when compared to the cylinder of each other group.
Figure 3 :High-resolution micro-computed-tomography of an implanted titanium cylinder. The inner thread was used for the implantation and the pull-out test

Click here to view

Mechanical testing

All samples were embedded in Technovit 4004 (Heraeus Kulzer GmbH, Wehrheim, Germany) and fixed in a special block. The fixation strength was measured by a MTS Mini Bionix 858 Test Star (MTS Systems Corporation, Minneapolis, USA). The mechanical testing was accomplished at a rate of 0.5 mm/sec with a longitudinal force direction to the implant axis. All data were recorded by the Test Star II software for statistical analysis.


Mean values and standard deviation were analyzed for all groups. Furthermore, the independent-samples t-test was used to analyze the differences in fixation strength and BV/TV between all groups. P < 0.05 was considered statistically significant.

   Results Top

No complications (e.g., infection, fracture) were found during the examination period of 28 days. All extracted samples could be used for the high-resolution micro-computed-tomography and biomechanical pull-out test.

High-resolution micro-computed-tomography

A region of interest was defined around each cylinder with 300 μm width. In this three-dimensional area, the software was able to differentiate between bone and nonbone (soft-tissue). To homogenize all received data independently of their implant location and bone stock quality in each animal, the control cylinder was assumed to be 100% bone ingrowth and the coated cylinders were compared relatively to the control in percentage. This enabled a comparison of all animals, independent of their individual cancellous bone stock in the condyle.

The highest ingrowth of implant was seen in the BMP-2 group (115.4 ± 7.5%), followed by the BMP-2 + TGF-b2 group (113.5 ± 7.2%). The copolymer + BMP-2 group was found to be 103.0 ± 2.3%. There were no significant differences between groups 2, 3, and 4.

BMP-2 group (P < 0.05) and BMP-2 + TGF-b2 group (P < 0.05) were significantly different compared to the control group. The copolymer + BMP-2 group was not significantly different compared to the control group (P=0.17) [Figure 4].
Figure 4 :Bar diagram showing osseointegration of implants. BV/ TV(%) with standard error of all groups (*significant difference to control group; P < 0.05)

Click here to view

Mechanical testing

The fixation strength was defined as the point of failure during the biomechanical pull-out test when the implant can be removed. To homogenize all received data independently of their implant location and bone stock quality of each animal, the control cylinder was assumed to be 100% fixation strength and the coated cylinders were compared relatively to the control in percentage. This enabled a comparison of all animals, independently of their individual cancellous bone stock in the condyle.

The highest pull-out strength was found in the BMP-2 group (192.5 ± 135.4%). The pull-out strength of the copolymer + BMP-2 group was 117.6 ± 49.1% and of the BMP-2 + TGF-b2 group was 113.0 ± 77.4%. There was no significant difference between control group and each other group (P > 0.5), but a trend of increased implant ingrowth especially in the BMP-2 group [Figure 5].
Figure 5 :Bar diagram showing maximum pull-out strength (N) with standard error of all groups. No significant differences between all groups

Click here to view

   Discussion Top

In this study, the effect of different titanium implant coatings on bone ingrowth was analyzed. Titanium implants without any surface coating served as control. All implants were implanted in the medial and lateral condyle of both femora in New Zealand White Rabbits.

In high-resolution micro-computed-tomography, we found a significant difference of the BMP-2 group (P < 0.05) and BMP-2 + TGF-β2 group (P < 0.05), compared to the control group. The combination of copolymer as an anchor for covalent binding of BMP-2 on the titanium surface showed an increase in implant ingrowth, but the difference was not significant. The pull-out test showed the same distribution, but no significant differences between coated implants and the control group.

Mechanical fixation of implants is an important consideration because this influences the response of the bone toward the implant and its . Three types of mechanical tests are commonly used: torque, push-in, and pull-out. In this study, pull-out was used because of the thinness of rabbit bone.

The ingrowth of implants in bone depends on bone remodeling and modeling by existing osteoblasts and osteoclasts. This leads to osseointegration of the implant. Differentiation of various cell types (undifferentiated mesenchymal stem cells, osteoprogenitor cells, monocytes) into osteoblasts and osteoclasts leads to osteoid production and mineralized bone under the influence of locally acting growth factors. BMPs, as a member of the TGF-β superfamily, have a variety of functions in the development and reparation of bone tissue. Several studies have shown the induction of osteoblast proliferation, differentiation, and influence on bone formation. [35],[36] Among more than 20 described isoforms, BMP-2, BMP-4, and BMP-7 play an important role in the bony skeletal system. Especially BMP-2 has been shown to have an important function in defect repair and implant osseointegration in maxillofacial surgery. [37],[38],[39],[40] Depending on their concentration gradient, BMPs can attract various types of cells, acting as differentiation, chemotactic or mitogenic agents. [41],[42],[43] In combination with BMP-2, TGF-b2 has been demonstrated to cause an increase in bone ingrowth in a canine study after 4 weeks on implants coated additionally with hydroxyapatite-tricalcium phosphate. [44] The combination of both growth factors has shown a synergistic effect on implant ingrowth through related but separate signal transduction pathways; TGF-β with control of osteoprogenitor cell proliferation, BMPs with more important influence in osteoblasts differentiation. [45],[46]

In the present study, the BMP-2 + TGF-β2 group showed a significant increase in high-resolution micro-computed-tomography but a nonsignificant increase in the mechanical testing. However, we have not found the clear superiority of BMP-2 + TGF-β2 compared to BMP-2 coating of implants as described in other studies. [44] A possible explanation may be the lower concentration of growth factors in the present study. Sumner et al. demonstrated that 12 μg TGF-β2 and 25 μg BMP-2 is the optimum dose. [44] Additionally they used a hydroxyapatite-tricalcium phosphate coating of each implant. In our study, we used 625 ng TGF-β2 and 12.5 μg BMP2 to simulate a more physiological concentration of both growth factors. In the copolymer group, BMP-2 was linked covalently to the copolymer via a limited number of binding sites for the growth factor. This led to a smaller amount of BMP-2 immobilized on the implant surface that was reflected by a minimal increase of bone ingrowth compared to the BMP-2 group and BMP-2 + TGF-b2 group.

A limitation of the present study may be the lower concentration of growth factors on the implant surface compared to other studies that makes an interpretation of our results in comparison to other studies more demanding. Furthermore, the small number of animals may lead to failures in statistics and might change to significant level with a higher amount of animals. However, this study does present an increase in implant ingrowth in all three groups compared to the control group, which reflects the potency of growth factors during implant ingrowth.

In future, one has to consider the use of growth factors especially in revision total hip arthroplasty with great loss of bone stock, which can possibly replace or be added to bone grafts that are commonly used in uncemented revision cases. [47] This may support surgeons in demanding and challenging situations. However, further studies with larger bone defects around implants should be conducted to transfer the results of small animal studies to large animals to define special doses of growth factors for individual defect and revision cases.

   Acknowledgments Top

The authors acknowledge the financial support of the collaborative research project (SFB 599) of the German Research Society (DFG).

   References Top

1.Sumner DR, Kienapfel H, Galante JO. Metallic implants. In: Habal MB, Reddi AH, editors. Bone Grafts and Bone Substitutes. Philadelphia: W. B. Saunders Company; 1992. p. 252-62.  Back to cited text no. 1
2.Jacobs JJ, Sumner DR, Urban RM, Galante JO. Retrieval: Successful uncemented implants. In: Mortey BF, editor. Biological, Material and Mechanical Considerations of Joint Replacement. New York: Raven Press; 1993. p. 185-95.  Back to cited text no. 2
3.Kontio R, Suuronen R, Konttinen YT, Hallikainen D, Lindqvist C, Kommonen B, et al. Orbital floor reconstruction with poly-L/D-lactide implants: Clinical, radiological and immunohistochemical study in sheep. Int J Oral Maxillofac Surg 2004;33:361-8.  Back to cited text no. 3
4.Hallman M, Sennerby L, Zetterqvist L, Lundgren S. A 3-year prospective follow-up study of implant-supported fixed prostheses in patients subjected to maxillary sinus floor augmentation with a 80:20 mixture of deproteinized bovine bone and autogenous bone clinical, radiographic and resonance frequency analysis. Int J Oral Maxillofac Surg 2005;34:273-80.  Back to cited text no. 4
5.Papalexiou V, Novaes AB Jr, Grisi MF, Souza SS, Taba M Jr, Kajiwara JK. Influence of implant microstructure on the dynamics of bone healing around immediate implants placed into periodontally infected sites. A confocal laser scanning microscopic study. Clin Oral Implants Res 2004;15:44-53.  Back to cited text no. 5
6.Berengo M, Sivolella S, Majzoub Z, Cordioli G. Endoscopic evaluation of the bone-added osteotome sinus floor elevation procedure. Int J Oral Maxillofac Surg 2004;33:189-94.  Back to cited text no. 6
7.Gaggl A, Rainer H, Chiari FM. Horizontal distraction of the anterior maxilla in combination with bilateral sinuslift operation: Preliminary report. Int J Oral Maxillofac Surg 2005;34:37-44.  Back to cited text no. 7
8.van der Meij EH, Blankestijn J, Berns RM, Bun RJ, Jovanovic A, Onland JM, et al. The combined use of two endosteal implants and iliac crest onlay grafts in the severely atrophic mandible by a modified surgical approach. Int J Oral Maxillofac Surg 2005;34:152-7.  Back to cited text no. 8
9.Celeste AJ, Iannazzi JA, Taylor RC, Hewick RM, Rosen V, Wang EA, et al. Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci U S A 1990;87:9843-7.  Back to cited text no. 9
10.Hotten GC, Matsumoto T, Kimura M, Bechtold RF, Kron R, Ohara T, et al. Recombinant human growth/differentiation factor 5 stimulates mesenchyme aggregation and chondrogenesis responsible for the skeletal development of limbs. Growth Factors 1996;13:65-74.  Back to cited text no. 10
11.Ozkaynak E, Rueger DC, Drier EA, Corbett C, Ridge RJ, Sampath TK, et al. OP-1 cDNA encodes an osteogenic protein in the TGF-beta family. EMBO J 1990;9:2085-93.  Back to cited text no. 11
12.Sampath TK, Maliakal JC, Hauschka PV, Jones WK, Sasak H, Tucker RF, et al. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J Biol Chem 1992;267:20352-62.  Back to cited text no. 12
13.Urist MR. Bone: Formation by autoinduction. Science 1965;150:893-9.  Back to cited text no. 13
14.Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, et al. Novel regulators of bone formation: Molecular clones and activities. Science 1988;242:1528-34.  Back to cited text no. 14
15.Sumner DR, Turner TM, Purchio AF, Gombotz WR, Urban RM, Galante JO. Enhancement of bone ingrowth by transforming growth factor-beta. J Bone Joint Surg Am 1995;77:1135-47.  Back to cited text no. 15
16.Sumner DR, Turner TM, Urban RM, Leven RM, Hawkins M, Nichols EH, et al. Locally delivered rhTGF-beta2 enhances bone ingrowth and bone regeneration at local and remote sites of skeletal injury. J Orthop Res 2001;19:85-94.  Back to cited text no. 16
17.Sumner DR, Turner TM, Cohen M, Losavio P, Urban RM, Nichols EH, et al. Aging does not lessen the effectiveness of TGFbeta2-enhanced bone regeneration. J Bone Miner Res 2003;18:730-6.  Back to cited text no. 17
18.Lind M, Overgaard S, Nguyen T, Ongpipattanakul B, Bunger C, Soballe K. Transforming growth factor-beta stimulates bone ongrowth. Hydroxyapatite-coated implants studied in dogs. Acta Orthop Scand 1996;67:611-6.  Back to cited text no. 18
19.Lind M, Overgaard S, Ongpipattanakul B, Nguyen T, Bunger C, Soballe K. Transforming growth factor-beta 1 stimulates bone ongrowth to weight-loaded tricalcium phosphate coated implants: An experimental study in dogs. J Bone Joint Surg Br 1996;78:377-82.  Back to cited text no. 19
20.Sumner DR, Turner TM, Urban RM, Turek T, Seeherman H, Wozney JM. Locally delivered rhBMP-2 enhances bone ingrowth and gap healing in a canine model. J Orthop Res 2004;22:58-65.  Back to cited text no. 20
21.Aspenberg P, Jeppsson C, Wang JS, Bostrom M. Transforming growth factor beta and bone morphogenetic protein 2 for bone ingrowth: A comparison using bone chambers in rats. Bone 1996;19:499-503.  Back to cited text no. 21
22.Cochran DL, Schenk R, Buser D, Wozney JM, Jones AA. Recombinant human bone morphogenetic protein-2 stimulation of bone formation around endosseous dental implants. J Periodontol 1999;70:139-50.  Back to cited text no. 22
23.Bragdon CR, Doherty AM, Rubash HE, Jasty M, Li XJ, Seeherman H, et al. The efficacy of BMP-2 to induce bone ingrowth in a total hip replacement model. Clin Orthop Relat Res 2003;417:50-61.  Back to cited text no. 23
24.Sigurdsson TJ, Fu E, Tatakis DN, Rohrer MD, Wikesjo UM. Bone morphogenetic protein-2 for peri-implant bone regeneration and osseointegration. Clin Oral Implants Res 1997;8:367-74.  Back to cited text no. 24
25.Lind M, Overgaard S, Song Y, Goodman SB, Bunger C, Soballe K. Osteogenic protein 1 device stimulates bone healing to hydroxyapaptite-coated and titanium implants. J Arthroplasty 2000;15:339-46.  Back to cited text no. 25
26.Soballe K, Jensen TB, Mouzin O, Kidder L, Bechtold JE. Differential effect of a bone morphogenetic protein-7 (OP-1) on primary and revision loaded, stable implants with allograft. J Biomed Mater Res A 2004;71:569-76.  Back to cited text no. 26
27.Cole BJ, Bostrom MP, Pritchard TL, Sumner DR, Tomin E, Lane JM, et al. Use of bone morphogenetic protein 2 on ectopic porous coated implants in the rat. Clin Orthop Relat Res 1997;345:219-28.  Back to cited text no. 27
28.Esenwein SA, Esenwein S, Herr G, Muhr G, Kusswetter W, Hartwig CH. Osteogenetic activity of BMP-3-coated titanium specimens of different surface texture at the orthotopic implant bed of giant rabbits. Chirurg 2001;72:1360-8.  Back to cited text no. 28
29.Hartwig CH, Esenwein SA, Pfund A, Kusswetter DW, Herr G. Improved osseointegration of titanium implants of different surface characteristics by the use of bone morphogenetic protein (BMP-3): An animal study performed at the metaphyseal bone bed in dogs. Z Orthop Ihre Grenzgeb 2003;141:705-11.  Back to cited text no. 29
30.Herr G, Hartwig CH, Boll C, Kusswetter W. Ectopic bone formation by composites of BMP and metal implants in rats. Acta Orthop Scand 1996;67:606-10.  Back to cited text no. 30
31.Kawai T, Mieki A, Ohno Y, Umemura M, Kataoka H, Kurita S, et al. Osteoinductive activity of composites of bone morphogenetic protein and pure titanium. Clin Orthop Relat Res 1993;290:296-305.  Back to cited text no. 31
32.Schmidmaier G, Wildemann B, Cromme F, Kandziora F, Haas NP, Raschke M. Bone morphogenetic protein-2 coating of titanium implants increases biomechanical strength and accelerates bone remodeling in fracture treatment: A biomechanical and histological study in rats. Bone 2002;30:816-22.  Back to cited text no. 32
33.Thorey F, Witte F, Nellesen J, Griep-Raming N, Menzel H, Gross G, et al. Improved osseointegration of titanium implants after surface coating with polymers in a rabbit model. Orthopade 2005;34:1112, 1114-7.  Back to cited text no. 33
34.Van OH, Duyck J, Vander SJ, Van der PG, Jansen J, Wevers M, et al. Use of microfocus computerized tomography as a new technique for characterizing bone tissue around oral implants. J Oral Implantol 2000;26:5-12.  Back to cited text no. 34
35.Asahina I, Sampath TK, Hauschka PV. Human osteogenic protein-1 induces chondroblastic, osteoblastic, and/or adipocytic differentiation of clonal murine target cells. Exp Cell Res 1996;222:38-47.  Back to cited text no. 35
36.Hughes FJ, Collyer J, Stanfield M, Goodman SA. The effects of bone morphogenetic protein-2, -4, and -6 on differentiation of rat osteoblast cells in vitro. Endocrinology 1995;136:2671-7.  Back to cited text no. 36
37.Higuchi T, Kinoshita A, Takahashi K, Oda S, Ishikawa I. Bone regeneration by recombinant human bone morphogenetic protein-2 in rat mandibular defects. An experimental model of defect filling. J Periodontol 1999;70:1026-31.  Back to cited text no. 37
38.Jovanovic SA, Hunt DR, Bernard GW, Spiekermann H, Nishimura R, Wozney JM, et al. Long-term functional loading of dental implants in rhBMP-2 induced bone. A histologic study in the canine ridge augmentation model. Clin Oral Implants Res 2003;14:793-803.  Back to cited text no. 38
39.Matin K, Senpuku H, Hanada N, Ozawa H, Ejiri S. Bone regeneration by recombinant human bone morphogenetic protein-2 around immediate implants: A pilot study in rats. Int J Oral Maxillofac Implants 2003;18:211-7.  Back to cited text no. 39
40.Sykaras N, Triplett RG, Nunn ME, Iacopino AM, Opperman LA. Effect of recombinant human bone morphogenetic protein-2 on bone regeneration and osseointegration of dental implants. Clin Oral Implants Res 2001;12:339-49.  Back to cited text no. 40
41.Reddi AH. Bone and cartilage differentiation. Curr Opin Genet Dev 1994;4:737-44.  Back to cited text no. 41
42.Sykaras N, Iacopino AM, Triplett RG, Marker VA. Effect of recombinant human bone morphogenetic protein-2 on the osseointegration of dental implants: A biomechanics study. Clin Oral Investig 2004;8:196-205.  Back to cited text no. 42
43.Wang EA, Rosen V, D'Alessandro JS, Bauduy M, Cordes P, Harada T, et al. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci U S A 1990;87:2220-4.  Back to cited text no. 43
44.Sumner DR, Turner TM, Urban RM, Virdi AS, Inoue N. Additive enhancement of implant fixation following combined treatment with rhTGF-beta2 and rhBMP-2 in a canine model. J Bone Joint Surg Am 2006;88:806-17.  Back to cited text no. 44
45.Cheng H, Jiang W, Phillips FM, Haydon RC, Peng Y, Zhou L, et al. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am 2003;85-A:1544-52.  Back to cited text no. 45
46.Fromigue O, Marie PJ, Lomri A. Bone morphogenetic protein-2 and transforming growth factor-beta2 interact to modulate human bone marrow stromal cell proliferation and differentiation. J Cell Biochem 1998;68:411-26.  Back to cited text no. 46
47.Hungerford DS, Mont MA. Revision of the femoral component: Proximal porous coating. In: Callaghan JJ, Rosenberg AG, Rubash HE, editors. The adult hip. Philadelphia: Lippincott-Raven; 1998. p. 1503-14.  Back to cited text no. 47

Correspondence Address:
Fritz Thorey
Department of Orthopaedic Surgery, Hannover Medical School, Anna-von-Borries-Str. 1-7, 30625 Hannover
Login to access the Email id

Source of Support: Research Project (SFB 599) of the German Research Society (DFG),, Conflict of Interest: None

DOI: 10.4103/0019-5413.73659

Rights and Permissions


  [Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5]

This article has been cited by
1 Propranolol enhances bone healing and implant osseointegration in rats tibiae
Ahmed E. Al-Subaie,Marco Laurenti,Mohamed-Nur Abdallah,Iskandar Tamimi,Farid Yaghoubi,Hazem Eimar,Nicholas Makhoul,Faleh Tamimi
Journal of Clinical Periodontology. 2016; 43(12): 1160
[Pubmed] | [DOI]
2 Novel hydrophilic nanostructured microtexture on direct metal laser sintered Ti-6Al-4V surfaces enhances osteoblast response in vitro and osseointegration in a rabbit model
Sharon L. Hyzy,Alice Cheng,David J. Cohen,Gustavo Yatzkaier,Alexander J. Whitehead,Ryan M. Clohessy,Rolando A. Gittens,Barbara D. Boyan,Zvi Schwartz
Journal of Biomedical Materials Research Part A. 2016; 104(8): 2086
[Pubmed] | [DOI]
3 Improved corrosion resistance and biocompatibility of a calcium phosphate coating on a magnesium alloy for orthopedic applications
Yongping Wang,Zhaojin Zhu,Xiangyang Xu,Yaohua He,Bingchun Zhang
European Journal of Inflammation. 2016; 14(3): 169
[Pubmed] | [DOI]
4 The Needs of Current Implant Technology in Orthopaedic Prosthesis Biomaterials Application to Reduce Prosthesis Failure Rate
Ahmad Jabir Rahyussalim,Aldo Fransiskus Marsetio,Ifran Saleh,Tri Kurniawati,Yudan Whulanza
Journal of Nanomaterials. 2016; 2016: 1
[Pubmed] | [DOI]
5 Biomaterial strategies for engineering implants for enhanced osseointegration and bone repair
Rachit Agarwal,Andrés J. García
Advanced Drug Delivery Reviews. 2015;
[Pubmed] | [DOI]
6 Layer-by-layer assembled cell instructive nanocoatings containing platelet lysate
Sara M. Oliveira,Vítor E. Santo,Manuela E. Gomes,Rui L. Reis,João F. Mano
Biomaterials. 2015; 48: 56
[Pubmed] | [DOI]
7 Extracellular signaling molecules to promote fracture healing and bone regeneration
K.D. Hankenson,K. Gagne,M. Shaughnessy
Advanced Drug Delivery Reviews. 2015; 94: 3
[Pubmed] | [DOI]
8 The promotion of osseointegration of titanium surfaces by coating with silk protein sericin
Nayak, S. and Dey, T. and Naskar, D. and Kundu, S.C.
Biomaterials. 2013; 34(12): 2855-2864
9 Microstructured titanium regulates interleukin production by osteoblasts, an effect modulated by exogenous BMP-2
Hyzy, S.L. and Olivares-Navarrete, R. and Hutton, D.L. and Tan, C. and Boyan, B.D. and Schwartz, Z.
Acta Biomaterialia. 2013; 9(3): 5821-5829
10 The promotion of osseointegration of titanium surfaces by coating with silk protein sericin
Sunita Nayak,Tuli Dey,Deboki Naskar,Subhas C. Kundu
Biomaterials. 2013; 34(12): 2855
[Pubmed] | [DOI]
11 Magnesium-based bone implants: Immunohistochemical analysis of peri-implant osteogenesis by evaluation of osteopontin and osteocalcin expression
A. Bondarenko,N. Angrisani,A. Meyer-Lindenberg,J. M. Seitz,H. Waizy,J. Reifenrath
Journal of Biomedical Materials Research Part A. 2013; : n/a
[Pubmed] | [DOI]
12 In Vivo Evaluation of a Novel Implant Coating Agent: Laminin-1
Kostas Bougas,Ryo Jimbo,Stefan Vandeweghe,Nick Tovar,Marta Baldassarri,Ali Alenezi,Malvin Janal,Paulo G. Coelho,Ann Wennerberg
Clinical Implant Dentistry and Related Research. 2013; : n/a
[Pubmed] | [DOI]
13 Microstructured titanium regulates interleukin production by osteoblasts, an effect modulated by exogenous BMP-2
S.L. Hyzy,R. Olivares-Navarrete,D.L. Hutton,C. Tan,B.D. Boyan,Z. Schwartz
Acta Biomaterialia. 2013; 9(3): 5821
[Pubmed] | [DOI]
14 Calcium phosphate coatings on magnesium alloys for biomedical applications: A review
Shaylin Shadanbaz,George J. Dias
Acta Biomaterialia. 2012; 8(1): 20
[Pubmed] | [DOI]
15 Novel Implant Coating Agent Promotes Gene Expression of Osteogenic Markers in Rats during Early Osseointegration
Kostas Bougas,Ryo Jimbo,Ying Xue,Kamal Mustafa,Ann Wennerberg
International Journal of Biomaterials. 2012; 2012: 1
[Pubmed] | [DOI]
16 Novel implant coating agent promotes gene expression of osteogenic markers in rats during early osseointegration
Bougas, K. and Jimbo, R. and Xue, Y. and Mustafa, K. and Wennerberg, A.
International Journal of Biomaterials. 2012; (579274)
17 Icariin: Can an herbal extract enhance dental implant outcomes?
Wang, Q. and Wang, X. and Xu, X.
Dental Hypotheses. 2012; 3(4): 133-137
18 Calcium phosphate coatings on magnesium alloys for biomedical applications: A review
Shadanbaz, S., Dias, G.J.
Acta Biomaterialia. 2012; 8(1): 20-30


    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Email Alert *
    Add to My List *
* Registration required (free)  

    Materials and Me...
    Article Figures

 Article Access Statistics
    PDF Downloaded115    
    Comments [Add]    
    Cited by others 18    

Recommend this journal